1HIV and Hepatitis Research Center, Shiraz University of Medical Sciences, Gerash, IR Iran
2Biotechnology Research Center, Pasteur Institute of Iran, Tehran, IR Iran
*Corresponding Author: HIV and Hepatitis Research Center, Shiraz University of Medical Sciences, Gerash, IR Iran, ayyoobfarsian@yahoo.com. Email: ayyoobfarsian@yahoo.com
Archives of Clinical Infectious Diseases:Vol. 3, issue 4; 215-9
Published online:Oct 31, 2008
Article type:Brief Report
Abstract
Background:
Resistance is the consequence of mutations that emerge in the viral proteins targeted by antiretroviral agents. Thus, we focused our attention on mutations in HIV-1 reverse transcriptase to define their association with specific NRTIs and NRTI resistance mutations at therapeutic failure.
Patients and methods:
The study population included 5 Iranian HIV-positive patients referring to Counseling Behavioral Modification Center in Shiraz who received a combination of antiretroviral therapy (lamivudine, stavudine and nevirapine). PBMC DNA was isolated from blood and PCR was performed to produce a 1200 bp amplicon and resolved by electrophoresis on a 0.7% agarose TBE gel, visualized with ethidium bromide. PCR products from HIV-1- infected patients were cloned into pCR2.1TOPO, then sequenced. Finally, sequence data were analyzed.
Results:
Results showed drug resistance in 2 patients, of whom one had NNRTI resistance mutations (M230G, L234R and K238H) and other had both NRTI (V75M) and NNRTI (F227L) resistance mutations.
Conclusion:
Confirmation of genetic resistance in HIV-positive patients who show therapy failure can help physicians to change their drug regime in order to achieve better outcome.
How to Cite:Bahmani MK, Khosravi A, Mahboodi F, SarramiForooshani R. Genotypic Correlation of a Virologic Response to Lamivudine, Stavudine and Nevirapine in Patients for Whom Combination Therapy Had Failed. Arch Clin Infect Dis. 2008;3(4):. doi:
Seyed Alinaghi SA, Rasoolinejad M, Najafi Z, Dadras O, Malekianzadeh E, et al. Drug Resistance Patterns in HIV Patients with Virologic Failure in Iran. Arch Clin Infect Dis. 2019;14(6):e96531. doi: https://doi.org/10.5812/archcid.96531
Shahzamani K, Sabzali S, Moetamedi S, Birjandi M, Zavari T. Exploring Virological Failure in HIV/AIDS Treatment: A Cross-sectional Study of Antiretroviral Regimen Efficacy and Predictors in Khorramabad City During 2011 - 2021. Jundishapur J Microbiol. 2026;19(5):e167579. doi: https://doi.org/10.5812/jjm-167579
Talei GR, Heydarifard Z, Khanizadeh S. Exploring Drug-Resistant Mutations in Protease Inhibitors and Subtype Distribution Among HIV-1 Positive Patients in Lorestan Province, Iran. Jundishapur J Microbiol. 2024;17(3):e145562. doi: https://doi.org/10.5812/jjm-145562
Rasoolinejad M, Sarraf M, Najafi Z, SeyedAlinaghi S, Moradmand Badie B, et al. Virologic Failure in Different Antiretroviral Regimens Among Pediatric Patients with HIV Referring to a Voluntary Counseling and Testing (VCT) Center in Tehran, Iran (2004 - 2017). Arch Pediatr Infect Dis. 2019;7(4):e80318. doi: https://doi.org/10.5812/pedinfect.80318